Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Ki67 Blocking Peptide (AC1214)
Cat.#: ACPP-1214
Specifications
Despition Ki67 Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1245 CRMP2 Blocking Peptide (AC1245) 250 µg inquiry ACPP-1839 Human Ornithine Aminotransferase Protein (AC1839) 5 µg inquiry ACPP-1343 GIRK1 Blocking Peptide (AC1343) 250 µg inquiry ACPP-1150 Synthetic Nanodisc Human TRPV1 Protein (AC1150) 10 µg inquiry ACPP-1727 Rat CNTF Protein (AC1727) 5 µg inquiry ACPP-1641 Adenylate cyclase 1 Blocking Peptide (AC1641) 250 µg inquiry ACPP-1522 Dopamine Receptor D3 Blocking Peptide (AC1522) 250 µg inquiry ACPP-1570 Human Acrp30 Protein, Trimeric (AC1570) 2 µg inquiry ACPP-1374 Human Ephrin A4 Protein (AC1374) 2 µg inquiry ACPP-1456 Human HEXA Protein (AC1456) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket